Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Air Products & Chemicals, Inc.APD · Entity 2983 | President, Europe & Africa | December 01, 2025 | December 03, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Air Products & Chemicals, Inc.
Report date December 01, 2025 · Filed December 03, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 12,833.641 |
Ending reported balance
After 2025-12-02 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2025-12-01 · Grant · Acquired 1,873 · Balance 11,960.641 F1: Not applicable to this security Row 2 · 2025-12-02 · Grant · Acquired 873 · Balance 12,833.641 F1: Not applicable to this security |
Filing footnotes · ownership attribution and instrument terms
F1: Not applicable to this security
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 02, 2025 Filed Dec 3, 2025 18:34 UTC | Air Products & Chemicals, Inc. APD · Entity 2983 | GrantCommon Stock | 873 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-009611 · doc4.xml · nonDerivative · entry 2 Bols Ivo · CIK 0002039734 · President, Europe & Africa 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,833.641 F1 · price: Not applicable to this security Read SEC document |
| December 01, 2025 Filed Dec 3, 2025 18:34 UTC | Air Products & Chemicals, Inc. APD · Entity 2983 | GrantCommon Stock | 1,873 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-009611 · doc4.xml · nonDerivative · entry 1 Bols Ivo · CIK 0002039734 · President, Europe & Africa 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,960.641 F1 · price: Not applicable to this security Read SEC document |
| February 18, 2025 Filed Feb 19, 2025 14:12 UTC | Air Products & Chemicals, Inc. APD · Entity 2983 | SaleCommon Stock | 18,000 | $313.82 | $5,648,760.00 |
DisclosureSEC source: 0001225208-25-001921 · doc4.xml · nonDerivative · entry 1 Bols Ivo · CIK 0002039734 · President, Europe & Africa 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,087.641 F1 · price: Actual sale price ranges from $312.63 - $315.88 Read SEC document |
| December 02, 2024 Filed Dec 3, 2024 20:28 UTC | Air Products & Chemicals, Inc. APD · Entity 2983 | GrantCommon Stock | 661 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-010433 · doc4.xml · nonDerivative · entry 2 Bols Ivo · CIK 0002039734 · President, Europe & Africa 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,087.641 F1 · price: Not applicable to this security Read SEC document |
| December 02, 2024 Filed Dec 3, 2024 20:28 UTC | Air Products & Chemicals, Inc. APD · Entity 2983 | GrantCommon Stock | 970 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-010433 · doc4.xml · nonDerivative · entry 1 Bols Ivo · CIK 0002039734 · President, Europe & Africa 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,426.641 F1 · price: Not applicable to this security Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.